Deerfield Management Company, L.P. (Series C) Oncology Institute, Inc. Call Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.76 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TOI
# of Institutions
40Shares Held
14.1MCall Options Held
83.9KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.78MShares$499,3670.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.75MShares$490,0000.37% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.73MShares$483,1570.0% of portfolio
-
Tiff Advisory Services Inc1.42MShares$397,2310.22% of portfolio
-
Triatomic Management LP New York, NY803KShares$224,83010.89% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $20.6M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...